# Zoetis Inc.: financial statements, quarterly

ZTS · NYSE · CIK 1555280 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/zts.md) · [Financials](/companies/zts/financials.md) · [Filings](/companies/zts/filings.md) · [Insiders](/companies/zts/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/zts/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,151](/filings/0001555280-24-000332.md) | [2,213 d](/filings/0001555280-26-000011.md) | [2,190](/filings/0001555280-25-000203.md) | [2,361](/filings/0001555280-25-000261.md) | [2,388](/filings/0001555280-25-000274.md) | [2,317 d](/filings/0001555280-26-000011.md) | [2,198](/filings/0001555280-26-000024.md) | [2,474](/filings/0001555280-26-000040.md) | [2,400](/filings/0001555280-25-000274.md) | [2,387 d](/filings/0001555280-26-000011.md) | [2,262](/filings/0001555280-26-000024.md) | [2,468](/filings/0001555280-26-000040.md) |
| Cost of revenue | $m | [638](/filings/0001555280-24-000332.md) | [728 d](/filings/0001555280-26-000011.md) | [643](/filings/0001555280-25-000203.md) | [668](/filings/0001555280-25-000261.md) | [701](/filings/0001555280-25-000274.md) | [707 d](/filings/0001555280-26-000011.md) | [618](/filings/0001555280-26-000024.md) | [664](/filings/0001555280-26-000040.md) | [683](/filings/0001555280-25-000274.md) | [712 d](/filings/0001555280-26-000011.md) | [641](/filings/0001555280-26-000024.md) | [673](/filings/0001555280-26-000040.md) |
| Selling, general and administrative | $m | [525](/filings/0001555280-24-000332.md) | [565 d](/filings/0001555280-26-000011.md) | [547](/filings/0001555280-25-000203.md) | [581](/filings/0001555280-25-000261.md) | [565](/filings/0001555280-25-000274.md) | [625 d](/filings/0001555280-26-000011.md) | [574](/filings/0001555280-26-000024.md) | [614](/filings/0001555280-26-000040.md) | [579](/filings/0001555280-25-000274.md) | [619 d](/filings/0001555280-26-000011.md) | [588](/filings/0001555280-26-000024.md) | [592](/filings/0001555280-26-000040.md) |
| Interest expense | $m | [59.0](/filings/0001555280-24-000332.md) | [59.0 d](/filings/0001555280-26-000011.md) | [58.0](/filings/0001555280-25-000203.md) | [59.0](/filings/0001555280-25-000261.md) | [57.0](/filings/0001555280-25-000274.md) | [51.0 d](/filings/0001555280-26-000011.md) | [54.0](/filings/0001555280-26-000024.md) | [53.0](/filings/0001555280-26-000040.md) | [58.0](/filings/0001555280-25-000274.md) | [57.0 d](/filings/0001555280-26-000011.md) | [62.0](/filings/0001555280-26-000024.md) | [61.0](/filings/0001555280-26-000040.md) |
| Income tax | $m | [121](/filings/0001555280-24-000332.md) | [127 d](/filings/0001555280-26-000011.md) | [148](/filings/0001555280-25-000203.md) | [156](/filings/0001555280-25-000261.md) | [182](/filings/0001555280-25-000274.md) | [151 d](/filings/0001555280-26-000011.md) | [171](/filings/0001555280-26-000024.md) | [186](/filings/0001555280-26-000040.md) | [166](/filings/0001555280-25-000274.md) | [158 d](/filings/0001555280-26-000011.md) | [157](/filings/0001555280-26-000024.md) | [175](/filings/0001555280-26-000040.md) |
| Net income | $m | [596](/filings/0001555280-24-000332.md) | [525 d](/filings/0001555280-26-000011.md) | [599](/filings/0001555280-25-000203.md) | [624](/filings/0001555280-25-000261.md) | [682](/filings/0001555280-25-000274.md) | [581 d](/filings/0001555280-26-000011.md) | [602](/filings/0001555280-26-000024.md) | [726](/filings/0001555280-26-000040.md) | [721](/filings/0001555280-25-000274.md) | [603 d](/filings/0001555280-26-000011.md) | [601](/filings/0001555280-26-000024.md) | [691](/filings/0001555280-26-000040.md) |
| Diluted EPS | $ per share | [1.29](/filings/0001555280-24-000332.md) | not reported | [1.31](/filings/0001555280-25-000203.md) | [1.37](/filings/0001555280-25-000261.md) | [1.50](/filings/0001555280-25-000274.md) | not reported | [1.34](/filings/0001555280-26-000024.md) | [1.63](/filings/0001555280-26-000040.md) | [1.63](/filings/0001555280-25-000274.md) | not reported | [1.42](/filings/0001555280-26-000024.md) | [1.65](/filings/0001555280-26-000040.md) |
| Basic EPS | $ per share | [1.29](/filings/0001555280-24-000332.md) | not reported | [1.31](/filings/0001555280-25-000203.md) | [1.37](/filings/0001555280-25-000261.md) | [1.51](/filings/0001555280-25-000274.md) | not reported | [1.34](/filings/0001555280-26-000024.md) | [1.63](/filings/0001555280-26-000040.md) | [1.63](/filings/0001555280-25-000274.md) | not reported | [1.42](/filings/0001555280-26-000024.md) | [1.65](/filings/0001555280-26-000040.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.8](/filings/0001555280-23-000247.md) | [2.0](/filings/0001555280-24-000332.md) | [2.0](/filings/0001555280-24-000249.md) | [1.6](/filings/0001555280-24-000299.md) | [1.7](/filings/0001555280-24-000332.md) | [2.0](/filings/0001555280-25-000274.md) | [1.7](/filings/0001555280-25-000203.md) | [1.4](/filings/0001555280-25-000261.md) | [2.1](/filings/0001555280-25-000274.md) | [2.5](/filings/0001555280-26-000040.md) | [1.9](/filings/0001555280-26-000024.md) | [1.5](/filings/0001555280-26-000040.md) |
| Current assets | $bn | [6.2](/filings/0001555280-23-000247.md) | [6.3](/filings/0001555280-25-000102.md) | [6.4](/filings/0001555280-24-000249.md) | [6.2](/filings/0001555280-24-000299.md) | [6.3](/filings/0001555280-24-000332.md) | [6.0](/filings/0001555280-26-000011.md) | [5.9](/filings/0001555280-25-000203.md) | [5.9](/filings/0001555280-25-000261.md) | [6.6](/filings/0001555280-25-000274.md) | [6.8](/filings/0001555280-26-000040.md) | [6.5](/filings/0001555280-26-000024.md) | [6.4](/filings/0001555280-26-000040.md) |
| Total assets | $bn | [14.1](/filings/0001555280-23-000247.md) | [14.3](/filings/0001555280-25-000102.md) | [14.3](/filings/0001555280-24-000249.md) | [14.2](/filings/0001555280-24-000299.md) | [14.4](/filings/0001555280-24-000332.md) | [14.2](/filings/0001555280-26-000011.md) | [14.1](/filings/0001555280-25-000203.md) | [14.5](/filings/0001555280-25-000261.md) | [15.2](/filings/0001555280-25-000274.md) | [15.5](/filings/0001555280-26-000040.md) | [15.2](/filings/0001555280-26-000024.md) | [15.1](/filings/0001555280-26-000040.md) |
| Current liabilities | $bn | [1.6](/filings/0001555280-23-000247.md) | [1.9](/filings/0001555280-25-000102.md) | [1.9](/filings/0001555280-24-000249.md) | [1.8](/filings/0001555280-24-000299.md) | [1.7](/filings/0001555280-24-000332.md) | [3.4](/filings/0001555280-26-000011.md) | [3.4](/filings/0001555280-25-000203.md) | [3.4](/filings/0001555280-25-000261.md) | [1.8](/filings/0001555280-25-000274.md) | [2.2](/filings/0001555280-26-000040.md) | [2.1](/filings/0001555280-26-000024.md) | [2.1](/filings/0001555280-26-000040.md) |
| Total liabilities | $bn | [9.0](/filings/0001555280-23-000247.md) | [9.3](/filings/0001555280-25-000102.md) | [9.3](/filings/0001555280-24-000249.md) | [9.2](/filings/0001555280-24-000299.md) | [9.1](/filings/0001555280-24-000332.md) | [9.5](/filings/0001555280-26-000011.md) | [9.4](/filings/0001555280-25-000203.md) | [9.5](/filings/0001555280-25-000261.md) | [9.8](/filings/0001555280-25-000274.md) | [12.1](/filings/0001555280-26-000040.md) | [11.9](/filings/0001555280-26-000024.md) | [11.9](/filings/0001555280-26-000040.md) |
| Long-term debt | $bn | [6.6](/filings/0001555280-23-000247.md) | [6.6](/filings/0001555280-25-000102.md) | [6.6](/filings/0001555280-24-000249.md) | [6.6](/filings/0001555280-24-000299.md) | [6.6](/filings/0001555280-24-000332.md) | [5.2](/filings/0001555280-26-000011.md) | [5.2](/filings/0001555280-25-000203.md) | [5.2](/filings/0001555280-25-000261.md) | [7.1](/filings/0001555280-25-000274.md) | [9.0](/filings/0001555280-26-000040.md) | [9.0](/filings/0001555280-26-000024.md) | [9.0](/filings/0001555280-26-000040.md) |
| Current portion of debt | $bn | [0.0](/filings/0001555280-23-000247.md) | [0.0](/filings/0001555280-25-000102.md) | not reported | not reported | not reported | [1.4](/filings/0001555280-26-000011.md) | [1.4](/filings/0001555280-25-000203.md) | [1.4](/filings/0001555280-25-000261.md) | [0.0](/filings/0001555280-25-000274.md) | [0.0](/filings/0001555280-26-000011.md) | not reported | not reported |
| Short-term borrowings | $bn | [0.0](/filings/0001555280-23-000247.md) | [0.0](/filings/0001555280-25-000102.md) | [0.0](/filings/0001555280-24-000249.md) | [0.0](/filings/0001555280-24-000299.md) | [0.0](/filings/0001555280-24-000332.md) | [0.0](/filings/0001555280-25-000102.md) | [0.0](/filings/0001555280-25-000203.md) | [0.0](/filings/0001555280-25-000261.md) | [0.0](/filings/0001555280-25-000274.md) | [0.0](/filings/0001555280-26-000040.md) | [0.0](/filings/0001555280-26-000024.md) | [0.0](/filings/0001555280-26-000040.md) |
| Shareholders' equity | $bn | [5.1](/filings/0001555280-23-000247.md) | [5.0](/filings/0001555280-25-000102.md) | [5.1](/filings/0001555280-24-000249.md) | [5.0](/filings/0001555280-24-000299.md) | [5.2](/filings/0001555280-24-000332.md) | [4.8](/filings/0001555280-26-000011.md) | [4.7](/filings/0001555280-25-000203.md) | [5.0](/filings/0001555280-25-000261.md) | [5.4](/filings/0001555280-25-000274.md) | [3.4](/filings/0001555280-26-000040.md) | [3.2](/filings/0001555280-26-000024.md) | [3.1](/filings/0001555280-26-000040.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings, us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [724 d](/filings/0001555280-24-000332.md) | [897 d](/filings/0001555280-26-000011.md) | [595](/filings/0001555280-25-000203.md) | [502 d](/filings/0001555280-25-000261.md) | [951 d](/filings/0001555280-25-000274.md) | [905 d](/filings/0001555280-26-000011.md) | [515](/filings/0001555280-26-000024.md) | [605 d](/filings/0001555280-26-000040.md) | [891 d](/filings/0001555280-25-000274.md) | [893 d](/filings/0001555280-26-000011.md) | [401](/filings/0001555280-26-000024.md) | [655 d](/filings/0001555280-26-000040.md) |
| Capital expenditure | $m | [145 d](/filings/0001555280-24-000332.md) | [198 d](/filings/0001555280-26-000011.md) | [140](/filings/0001555280-25-000203.md) | [132 d](/filings/0001555280-25-000261.md) | [167 d](/filings/0001555280-25-000274.md) | [216 d](/filings/0001555280-26-000011.md) | [178](/filings/0001555280-26-000024.md) | [146 d](/filings/0001555280-26-000040.md) | [136 d](/filings/0001555280-25-000274.md) | [161 d](/filings/0001555280-26-000011.md) | [110](/filings/0001555280-26-000024.md) | [117 d](/filings/0001555280-26-000040.md) |
| Share repurchases | $m | [250 d](/filings/0001555280-24-000332.md) | [235 d](/filings/0001555280-26-000011.md) | [339](/filings/0001555280-25-000203.md) | [533 d](/filings/0001555280-25-000261.md) | [433 d](/filings/0001555280-25-000274.md) | [553 d](/filings/0001555280-26-000011.md) | [443](/filings/0001555280-26-000024.md) | [338 d](/filings/0001555280-26-000040.md) | [394 d](/filings/0001555280-25-000274.md) | [2,060 d](/filings/0001555280-26-000011.md) | [606](/filings/0001555280-26-000024.md) | [584 d](/filings/0001555280-26-000040.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [469](/filings/0001555280-23-000247.md) | [465](/filings/0001555280-24-000249.md) | [463](/filings/0001555280-24-000299.md) | [461](/filings/0001555280-24-000332.md) | [459](/filings/0001555280-25-000203.md) | [456](/filings/0001555280-25-000261.md) | [454](/filings/0001555280-25-000274.md) | [448](/filings/0001555280-26-000024.md) | [446](/filings/0001555280-26-000040.md) | [443](/filings/0001555280-25-000274.md) | [422](/filings/0001555280-26-000024.md) | [418](/filings/0001555280-26-000040.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 413,223,602 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001555280-26-000040.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.